Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2605-2616

  Neurath, Markus F ^a   Fuss, Ivan ^a   Kelsall, Brian L ^a   Presky, David H ^b   Waegell, Wendy ^c   Strober, Warren ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c Celtrix Pharmaceutical Co   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; COLITIS; GRANULOMATOUS INFLAMMATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; CYTOKINES; FEMALE; GRANULOMATOUS DISEASE, CHRONIC; HAPTENS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-10; INTERLEUKIN-4; INTESTINAL MUCOSA; MICE; MICE, INBRED STRAINS; OVALBUMIN; PEYER'S PATCHES; T-LYMPHOCYTES; TH1 CELLS; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID;

EID: 0029995799     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2605     Document Type: Article

References (30)

1. Miller, A., O. Lider, A.B. Roberts, M.B. Sporn, and H.L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA. 89:421-425.
2. Khoury, S.J., W.W. Hancock, and H.L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176: 1355-1364.
3. Nagler-Anderson, C., A. Bober, M. Robinson, G. Siskind, and G. Thorbecke. 1983. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. USA. 83:7443-7446.
4. Zhang, Z., C. Lee, O. Lider, and H.L. Weiner. 1990. Suppression of adjuvant arthritis by oral administration of type II collagen. J. Immunol. 145:2489-2493.
5. Zhang, Z.J., L.E. Davidsen, G. Eisenbarth, and H.L. Weiner. 1991. Suppression of diabetes in NOD mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA. 88: 10252-10256.
6. Gregerson, D.S., W.F. Obritsch, and L.A. Donoso. 1993. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J. Immunol. 151:5751-5761.
7. Nussenblatt, R., R. Caspi, R. Mahdi, C. Chan, F. Roberge, O. Lider, and H.L. Weiner. 1989. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance by S-antigen. J. Immunol. 144:1689-1699.
8. Friedman, A., and H.L. Weiner. 1994. Induction of anergy or active suppression in oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA. 91:6688-6692.
9. Weiner, H.L. 1994. Oral tolerance. Proc. Natl. Acad. Sci. USA. 91:10762-10765.
10. Podolsky, D.K. 1991. Inflammatory bowel disease. New Engl. J. Med. 325:928-935.
11. Strober, W., and M.F. Neurath. 1995. Immunological diseases of the gastrointestinal tract. In Clinical Immunology. Mosby, St. Louis. R.R. Rich, editor. 1401-1428.
12. Hammer, R.E., S.D. Maika, J.A. Richardson, Y.P. Tang, and J.D. Taurog. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA 1327 and human β2m: an animal model of HLAB-27-associated human disorders. Cell. 63: 1099-1112.
13. Holländer, G.A., S.J. Simpson, E. Mizoguchi, A. Nichogiannopoulou, J. She, J.-C. Gutierrez-Ramos, A.K. Bhan, S.J. Burakoff, B. Wang, and C. Terhorst. 1995. Severe colitis in mice with aberrant thymic selection. Immunity. 3:27-38.
14. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A.C. Feller, and I. Horvak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:253-261.
15. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
16. i2-deficient mice. Nat. Genet. 10:143-146.
17. Mombaerts, P., E. Mizoguchi, M.J. Grusby, L.H. Glimcher, A.K. Bahn, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:275-282.
18. Powrie, F., M.W. Leach, S. Mauze, S. Menon, L.B. Caddle, and R.L. Coffman. 1994. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity. 1:553-562.
19. Massague, J. 1990. Transforming growth factor beta. Annu. Rev. Cell. Biol. 6:597-646.
20. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschmann. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammation. Nature (Lond.). 359:693-699.
21. 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:770-774.
22. Neurath, M.F., I. Fuss, B.L. Kelsall, E. Stüber, and W. Strober. 1995. Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281-1290.
23. Van der Heijden, P.J., and W. Stok. 1987. Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine. J. Immunol. Methods. 103:161-167.
24. Crowley, M.K., M. Inaba, M. Witmer-Pack, and R.M. Steinman. 1989. The cell surface of mouse dendritic cells: FACS analysis of dendritic cells from different tissues including thymus. Cell Immunol. 118:108-125.
25. Miller, A., O. Lider, and H.L. Weiner. 1991. Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174:791-798.
26. Chen, Y., V.K. Kuchroo, J.I. Inobe, D.A. Hafler, and H.L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalitis. Science (Wash. DC). 265:1237-1240.
27. Chen, Y, J.I. Inobe, R. Marks, P. Gonnella, V.K. Kuchroo, and H.L. Weiner. 1995. Peripheral deletion of antigen-reactive T cells following oral tolerance. Nature (Lond.). 376:177-180.
28. Schmitt, E., P. Hoehn, C. Huels, S. Goedert, N. Palm, E. Rüde, and T. Germann. 1994. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24:793-798.
29. Trentham, D.E., R.A. Dynesius-Trentham, E.J. Orav, D. Combitchi, C. Lorenzo, K.L. Sewell, D.A. Hafler, and H.L. Weiner. 1993. Effects of oral administration of type II collagen on rheumatoid arthritis. Science (Wash. DC). 261:1727-1730.
30. Weiner, H.L., G.A. Mackin, M. Matsui, E.J. Orav, S.J. Khoury, D.M. Dawson, and D.A. Hafler. 1993. Double-blind pilot trial of oral tolerization with myelin antigen in multiple sclerosis. Science (Wash. DC). 261:1321-1324.